Casperome® (Boswellia Phytosome — Indena)

Boswellia serrata
Evidence Level
Strong
2 Clinical Trials
5 Documented Benefits
4/5 Evidence Score

Casperome® is a BOSWELLIA SERRATA PHYTOSOME® formulation developed by Indena (Italy) — using Phytosome® technology to enhance bioavailability of boswellic acids. Distinguished by FULL SPECTRUM 11 boswellic acids (not just KBA + AKBA like many products), bioabsorption optimized at plasma AND tissue levels, and 10+ human studies. Used for: musculoskeletal health, allergy season airway support, gut health (acute diarrhea support).

Studied Dose 250 mg twice daily (research-validated dose)
Active Compound Boswellia serrata gum resin acids (full spectrum 11 boswellic acids; Phytosome® formulation)

Benefits

Musculoskeletal Health (Athletes)

Casperome supports musculoskeletal health by reducing stress and inflammatory status of joints and muscles in actual athletes. Athletic recovery and joint support applications.

Allergy Season Airway Support

Boswellic acids inhibit lipoxygenase pathway (responsible for leukotrienes — central in allergic respiratory responses); Casperome supports airway comfort during allergy season.

Gut Health / Acute Diarrhea Support

Recent clinical evidence reports Casperome's role in supporting gut health in specific conditions including acute diarrhea. Mechanism via boswellic acids as Ca2+ channel modulators in intestinal smooth muscle.

Bioavailability Optimization

Boswellic acids are normally poorly soluble; Phytosome® delivery system optimizes bioabsorption at plasma AND tissue levels (unlike many products that improve plasma but not tissue delivery).

Full-Spectrum Boswellic Acids

Contains all 11 relevant boswellic acids matching natural Boswellia serrata resin composition — distinguishes from AKBA-only or KBA+AKBA products. Comprehensive activity profile.

Mechanism of action

1

Phytosome® Boswellic Acid Bioavailability

Boswellic acids have poor inherent solubility and absorption; Phytosome® complexes with phosphatidylcholine for enhanced absorption; reaches target tissues including joints, airways, gut.

2

5-Lipoxygenase (5-LOX) Inhibition

Boswellic acids inhibit 5-LOX — enzyme producing leukotrienes (inflammatory mediators); distinguishes from NSAID COX-only inhibition; relevant for inflammatory conditions where leukotrienes are central (asthma, IBD, joint inflammation).

3

Cathepsin G and NF-κB Inhibition

Boswellic acids inhibit cathepsin G (protease) and NF-κB pathway — multiple inflammatory pathway modulation.

4

TNF-α and Matrix Metalloproteinase Reduction

Reduces overexpression of TNF-α and matrix metalloproteinases (MMPs) — relevant to chronic inflammatory conditions including joint degradation.

5

Ca2+ Channel Modulation in Intestinal Smooth Muscle

Boswellic acids modulate calcium channels in intestinal smooth muscle — mechanism for gut applications including diarrhea support.

Clinical trials

1
Casperome for Joint Health — Multiple Trials
PubMed

Multiple Casperome trials for joint stress and inflammation in athletes and general populations.

Athletes and adults with joint concerns.

Significant improvements in joint discomfort, inflammatory markers, mobility.

2
Casperome for Allergy / Airway Support
PubMed

Studies of Casperome on airway comfort during allergy season.

Adults with seasonal airway concerns.

Symptom improvements via leukotriene pathway modulation.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
Mild GI distress.
Allergic reactions rare.
Soy lecithin allergy considerations (Phytosome phosphatidylcholine source) — verify product.

Important Drug interactions

ANTICOAGULANTS — modest antiplatelet effects.
Antihypertensives — modest effects.
5-LOX inhibitors (zileuton) — same mechanism; theoretical additive.
Pregnancy — limited safety data; AVOID supplementation.
Lactation — limited data.
SOY ALLERGY — Phytosome phosphatidylcholine source consideration.
Pre-surgery — discontinue 1-2 weeks before.

Frequently asked questions about Casperome® (Boswellia Phytosome — Indena)

What is the recommended dosage of Casperome® (Boswellia Phytosome — Indena)?

The clinically studied dose for Casperome® (Boswellia Phytosome — Indena) is 250 mg twice daily (research-validated dose). Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Casperome® (Boswellia Phytosome — Indena) used for?

Casperome® (Boswellia Phytosome — Indena) is studied for musculoskeletal health (athletes), allergy season airway support, gut health / acute diarrhea support. Casperome supports musculoskeletal health by reducing stress and inflammatory status of joints and muscles in actual athletes. Athletic recovery and joint support applications.

Are there side effects from taking Casperome® (Boswellia Phytosome — Indena)?

Reported potential side effects may include: Generally well-tolerated. Mild GI distress. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Does Casperome® (Boswellia Phytosome — Indena) interact with medications?

Known drug interactions may include: ANTICOAGULANTS — modest antiplatelet effects. Antihypertensives — modest effects. Consult a pharmacist or healthcare provider if you take prescription medications.

Is Casperome® (Boswellia Phytosome — Indena) good for joint health?

Yes, Casperome® (Boswellia Phytosome — Indena) is researched for Joint Health support. Casperome supports musculoskeletal health by reducing stress and inflammatory status of joints and muscles in actual athletes. Athletic recovery and joint support applications.